A high-level delegation from the Uttar Pradesh government has embarked on a significant investment outreach mission in Hyderabad, aiming to position the state as a premier destination for pharmaceutical and life sciences industries. Led by the Chief Minister's advisor, Awnish Awasthi, the delegation held a series of crucial meetings with major industry players to discuss concrete opportunities.
Key Meetings with Industry Leaders
The delegation engaged in detailed discussions with several prominent companies and industry bodies. The talks focused on forging partnerships in pharmaceutical manufacturing, medical research, and sustainable industrial infrastructure. Among the key entities met were Dr. Reddy's Laboratories, Aurore Life Science, Ramky Group, and the Federation of Telangana Chambers of Commerce and Industry (FTCCI).
During these interactions, the UP officials presented a compelling case for the state's readiness. They highlighted specific investment-ready sites including the Lalitpur Pharma Park, Hathras Industrial Area, Bulandshahr, and Sandila. The companies showed keen interest in exploring possibilities for setting up manufacturing facilities, entering into research collaborations, and forming infrastructure partnerships.
Showcasing UP's Strategic Advantages
The delegation emphasised Uttar Pradesh's ambitious vision and supportive ecosystem. Aligned with the state government's goal of achieving a $1 trillion economy, the officials outlined the rapidly expanding medical education and research landscape in UP. They also underscored the robust policy support and the administration's unwavering commitment to transforming the state into a leading hub for life sciences and healthcare innovation.
Continued Engagement and Major Conclave
The investment drive in Hyderabad is set to continue with more scheduled meetings. The delegation plans to engage with the Bulk Drug Manufacturers Association of India (BDMAI), IKP Knowledge Park, and the Indian Pharmaceutical Association (IPA). These discussions aim to further solidify industry partnerships and attract diverse investments.
In a significant move to consolidate interest, all companies and industry bodies have been formally invited to participate in the upcoming Pharma Conclave. This major event is scheduled to be held on February 3 in Lucknow, serving as a platform for deeper dialogue and commitment.
This proactive outreach marks a strategic step by the Uttar Pradesh government to tap into the expertise and capital of Hyderabad's established pharmaceutical cluster, directly supporting its broader economic ambitions.
